Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

Stopped early · Phase 2

Conditions studied: Stroke, Brain Ischemia, Vasospasm, Intracranial, Hemorrhage, Intracranial

In brief

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and need to undergo endovascular therapy require constant assessment of their neurological status prior, during and after the interventional procedure. In this study the investigators will compare the efficacy of Dexmedetomidine to other standard sedative medications in providing optimal sedative effect while maintaining neurological function.

Key facts

Study ID
NCT01845441
Run by
University Hospitals Cleveland Medical Center
People needed
7
Starts
2012-04-01
Expected to finish
2021-12-01
Last updated by the study team
2022-12-28

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.